- Home
- CAH vs CCEP Comparison
CAH vs CCEP Comparison
Compare CAH & CCEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAH
- CCEP
- Stock Information
- Founded
- CAH 1979
- CCEP 1986
- Country
- CAH United States
- CCEP United Kingdom
- Employees
- CAH N/A
- CCEP N/A
- Industry
- CAH Other Pharmaceuticals
- CCEP Beverages (Production/Distribution)
- Sector
- CAH Health Care
- CCEP Consumer Staples
- Exchange
- CAH Nasdaq
- CCEP Nasdaq
- Market Cap
- CAH 29.6B
- CCEP 35.5B
- IPO Year
- CAH N/A
- CCEP 1987
- Fundamental
- Price
- CAH $127.84
- CCEP $77.64
- Analyst Decision
- CAH Buy
- CCEP Strong Buy
- Analyst Count
- CAH 13
- CCEP 8
- Target Price
- CAH $132.46
- CCEP $84.86
- AVG Volume (30 Days)
- CAH 2.1M
- CCEP 1.5M
- Earning Date
- CAH 01-30-2025
- CCEP 02-21-2025
- Dividend Yield
- CAH 1.59%
- CCEP 2.75%
- EPS Growth
- CAH 539.70
- CCEP N/A
- EPS
- CAH 5.21
- CCEP 3.75
- Revenue
- CAH $224,454,000,000.00
- CCEP $20,521,804,348.00
- Revenue This Year
- CAH N/A
- CCEP $14.83
- Revenue Next Year
- CAH $8.30
- CCEP $4.74
- P/E Ratio
- CAH $24.55
- CCEP $20.82
- Revenue Growth
- CAH 6.87
- CCEP 6.31
- 52 Week Low
- CAH $93.17
- CCEP $65.77
- 52 Week High
- CAH $127.79
- CCEP $82.32
- Technical
- Relative Strength Index (RSI)
- CAH 71.00
- CCEP 58.01
- Support Level
- CAH $119.25
- CCEP $74.84
- Resistance Level
- CAH $122.83
- CCEP $76.25
- Average True Range (ATR)
- CAH 2.18
- CCEP 1.31
- MACD
- CAH 0.86
- CCEP 0.24
- Stochastic Oscillator
- CAH 99.52
- CCEP 81.70
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About CCEP Coca-Cola Europacific Partners plc
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe (80% of 2023 revenue and EBIT) and Australasia (20%).In 2023, CCEP sold 3.3 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume. Coke's largest bottler, Coca-Cola Femsa sold 4 billion unit cases (12%), and the third-largest, Coca-Cola HBC, serving Eastern Europe and North Africa, sold 2.8 billion unit cases (8%).TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.